Lars Wallentin Selected Research

Ischemic Stroke

3/2024	Repeated Measurement of the Novel Atrial Biomarker BMP10 (Bone Morphogenetic Protein 10) Refines Risk Stratification in Anticoagulated Patients With Atrial Fibrillation: Insights From the ARISTOTLE Trial.
1/2023	Outcomes of patients with atrial fibrillation and ischemic stroke while on oral anticoagulation.
1/2023	Plasma angiopoietin-2 and its association with heart failure in patients with atrial fibrillation.
1/2023	Bone morphogenetic protein 10: a novel risk marker of ischaemic stroke in patients with atrial fibrillation.
1/2022	Genetic determinants of apixaban plasma levels and their relationship to bleeding and thromboembolic events.
12/2020	Screening of Multiple Biomarkers Associated With Ischemic Stroke in Atrial Fibrillation.
1/2018	Apixaban following acute coronary syndromes in patients with prior stroke: Insights from the APPRAISE-2 trial.
1/2016	Contemporary use of ticagrelor in patients with acute coronary syndrome: insights from Swedish Web System for Enhancement and Development of Evidence-Based Care in Heart Disease Evaluated According to Recommended Therapies (SWEDEHEART).
12/2015	Interleukin-6 and C-reactive protein and risk for death and cardiovascular events in patients with atrial fibrillation.
8/2015	Apixaban Plus Mono Versus Dual Antiplatelet Therapy in Acute Coronary Syndromes: Insights From the APPRAISE-2 Trial.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lars Wallentin Research Topics

Disease

187	Stroke (Strokes) 03/2024 - 05/2004
183	Hemorrhage 01/2024 - 05/2002
170	Acute Coronary Syndrome 04/2024 - 06/2002
164	Myocardial Infarction 12/2023 - 02/2002
150	Atrial Fibrillation 03/2024 - 05/2003
64	Embolism (Embolus) 01/2024 - 09/2009
54	Coronary Artery Disease (Coronary Atherosclerosis) 12/2023 - 05/2002
41	Thrombosis (Thrombus) 01/2021 - 05/2002
33	Heart Failure 12/2023 - 06/2002
31	Inflammation (Inflammations) 12/2023 - 12/2003
31	ST Elevation Myocardial Infarction 06/2022 - 04/2003
26	Coronary Disease (Coronary Heart Disease) 12/2023 - 05/2002
24	Atherosclerotic Plaque (Atheroma) 01/2022 - 05/2002
23	Cardiovascular Diseases (Cardiovascular Disease) 01/2023 - 06/2003
18	Ischemia 12/2023 - 07/2003
16	Ischemic Stroke 03/2024 - 03/2010
15	Diabetes Mellitus 01/2021 - 06/2002
15	Heart Diseases (Heart Disease) 11/2018 - 04/2007
12	Unstable Angina 01/2013 - 05/2002
11	Chronic Renal Insufficiency 12/2021 - 09/2010
11	Transient Ischemic Attack 04/2019 - 02/2010
9	Hypertension (High Blood Pressure) 01/2022 - 02/2010
9	Infarction (Infarctions) 01/2019 - 02/2002
9	Intracranial Hemorrhages (Intracranial Hemorrhage) 12/2018 - 05/2006
8	Body Weight (Weight, Body) 01/2024 - 07/2003
8	Obesity 12/2019 - 08/2013
8	Non-ST Elevated Myocardial Infarction 09/2019 - 11/2007
7	Atherosclerosis 12/2023 - 02/2012
7	Necrosis 06/2022 - 12/2003
7	Hemorrhagic Stroke 01/2020 - 09/2009
6	Neoplasms (Cancer) 12/2017 - 03/2010
5	Infections 01/2022 - 10/2012
4	Thromboembolism 01/2021 - 03/2015
4	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 01/2021 - 02/2014
4	Sudden Death 10/2018 - 10/2012
4	Death (Near-Death Experience) 02/2015 - 02/2012
3	Type 2 Diabetes Mellitus (MODY) 01/2022 - 11/2013
3	COVID-19 01/2022 - 11/2020

Drug/Important Bio-Agent (IBA)

108	Warfarin (Coumadin)FDA LinkGeneric 03/2024 - 05/2003
89	apixabanIBA 03/2024 - 06/2009
78	Biomarkers (Surrogate Marker)IBA 03/2024 - 07/2003
75	Clopidogrel (Plavix)FDA Link 11/2022 - 05/2003
68	TicagrelorIBA 11/2022 - 04/2009
47	AnticoagulantsIBA 01/2024 - 05/2003
42	Dabigatran FDA Link 01/2024 - 11/2007
41	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2024 - 07/2003
40	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 11/2021 - 02/2002
36	pro-brain natriuretic peptide (1-76)IBA 01/2024 - 07/2003
35	Growth Differentiation Factor 15IBA 01/2024 - 02/2007
29	Troponin T (Troponin T1)IBA 01/2024 - 05/2002
24	CreatinineIBA 01/2023 - 06/2002
24	darapladibIBA 01/2022 - 10/2010
23	C-Reactive ProteinIBA 01/2024 - 03/2003
23	TroponinIBA 01/2021 - 05/2002
21	Cystatin CIBA 01/2024 - 10/2004
20	Vitamin K FDA Link 01/2024 - 05/2009
19	Thrombin Receptors (Thrombin Receptor)IBA 11/2022 - 01/2012
19	Dalteparin (Dalteparin Sodium)FDA Link 02/2012 - 05/2002
18	vorapaxarIBA 11/2022 - 01/2012
16	Interleukin-6 (Interleukin 6)IBA 01/2024 - 12/2003
16	Heparin (Liquaemin)FDA LinkGeneric 09/2019 - 02/2002
13	Troponin IIBA 01/2021 - 06/2003
13	Prasugrel Hydrochloride FDA Link 01/2020 - 05/2006
12	Proteins (Proteins, Gene)FDA Link 03/2024 - 01/2011
11	Glycoproteins (Glycoprotein)IBA 09/2019 - 10/2002
11	Enoxaparin (Lovenox)FDA LinkGeneric 02/2010 - 08/2003
10	1-Alkyl-2-acetylglycerophosphocholine Esterase (PAF Acetylhydrolase)IBA 01/2024 - 03/2006
9	Fondaparinux (Arixtra)FDA Link 02/2015 - 12/2005
8	Thrombin FDA Link 01/2020 - 05/2002
8	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 04/2016 - 05/2002
7	omega-Chloroacetophenone (Mace)IBA 12/2023 - 10/2010
7	LDL CholesterolIBA 01/2020 - 03/2006
7	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2019 - 08/2006
7	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 02/2015 - 05/2002
6	Trinitrotoluene (TNT)IBA 06/2022 - 03/2003
6	Natriuretic PeptidesIBA 11/2021 - 09/2004
6	Fibrinolytic Agents (Antithrombotic Agents)IBA 06/2015 - 05/2004
6	Tenecteplase FDA Link 10/2006 - 08/2003
6	Abciximab (ReoPro)FDA Link 10/2006 - 08/2003
5	Triglycerides (Triacylglycerol)IBA 01/2022 - 03/2006
5	AntithrombinsIBA 11/2011 - 02/2004
5	Factor Xa InhibitorsIBA 09/2011 - 12/2005
4	RivaroxabanIBA 01/2023 - 04/2012
4	Cytochrome P-450 CYP2C19IBA 01/2021 - 07/2009
4	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 01/2020 - 01/2017
4	LDL Lipoproteins (beta Lipoproteins)IBA 11/2019 - 03/2006
4	fibrin fragment D (D-dimer)IBA 01/2017 - 02/2002
4	MetalsIBA 09/2014 - 03/2007
3	LigandsIBA 01/2023 - 11/2019
3	Factor Xa (Coagulation Factor Xa)IBA 01/2023 - 12/2005
3	Blood Proteins (Serum Proteins)IBA 01/2023 - 12/2020

Therapy/Procedure

136	Therapeutics 01/2024 - 02/2002
34	Percutaneous Coronary Intervention 04/2024 - 10/2002
27	Stents 01/2021 - 03/2007
17	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 12/2018 - 05/2004
10	Critical Care (Surgical Intensive Care) 11/2013 - 10/2004
9	Patient Readmission 03/2017 - 07/2008
7	Conservative Treatment 12/2023 - 07/2008
7	Secondary Prevention 01/2021 - 08/2006
4	Catheters 06/2015 - 10/2007